KIDS OrthoPediatrics Corp

OrthoPediatrics Corp. Announces Distribution Agreement with MY01 Inc.

OrthoPediatrics Corp. Announces Distribution Agreement with MY01 Inc.

Advancing Care for Pediatric Trauma Patients

WARSAW, Ind., Sept. 05, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics announced today a new distribution partnership with MY01, an innovative medical technology company focused on transforming the diagnosis of limb perfusion injuries. This collaboration will expand access to MY01’s Continuous Perfusion Sensing Technology™ (CPST™) Platform for children and adolescents, a population at great risk for acute compartment syndrome.

Acute compartment syndrome is a time-sensitive emergency that disproportionately affects children with a floating elbow1, tibial2 and forearm3 fractures, and other orthopedic traumatic injuries4. Diagnosing acute compartment syndrome in pediatric patients can be challenging: children may struggle to verbalize pain, and early warning signs are often subtle.

“This partnership isn’t just about scale, it’s about impact,” commented Andrew Morris, Chief Commercial Officer at MY01. “Children represent the group most at-risk for compartment syndrome, and with OrthoPediatrics we can ensure clinicians have access to the right tools, at the right time, to avoid unnecessary surgeries and life-altering complications such as limb loss for these patients."

“At OrthoPediatrics, we’ve always been driven by one goal: to help children whose lives have been impacted by orthopedic conditions,” said Fady Rayes, Vice-President of Product Development. “Partnering with MY01 extends that mission into trauma monitoring, pairing innovative technology with our focus on education and surgeon support.”

By combining MY01’s CPST Platform with OrthoPediatrics’ dedicated pediatric sales force and commitment to medical education, clinicians will gain the tools and training needed to reduce variability in care, ensuring optimized outcomes for all pediatric patients.

About MY01

Founded in 2019 and based in Montreal, MY01 envisions a world where every disease is quantifiable, allowing for precise, personalized care for all patients. Our Continuous Perfusion Sensing Technology (CPST) Platform has the potential to transform trauma programs by translating complex biological signs into dynamic, actionable, real-time data that supports better decision-making. This reduces variations in care and delivers improved outcomes, enabling hospitals to allocate resources as efficiently as possible. MY01 is currently operational in the USA, Europe, and Canada, setting new standards in healthcare.

About OrthoPediatrics Corp.

Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 80 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit . For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit .

1 Blakemore, L. C., Cooperman, D. R., Thompson, G. H., Wathey, C., & Ballock, R. T. (2000). Compartment syndrome in ipsilateral humerus and forearm fractures in children. Clin Orthop Relat Res(376), 32-38.

2 Obey, M. R., Shlykov, M. A., Nickel, K. B., Keller, M., & Hosseinzadeh, P. (2023). Incidence and risk factors for acute compartment syndrome in pediatric tibia fractures. J Pediatr Orthop B, 32(4), 401-404.

3 Grottkau, B. E., Epps, H. R., & Di Scala, C. (2005). Compartment syndrome in children and adolescents. J Pediatr Surg, 40(4), 678-682.

4 Bae, D. S., Kadiyala, R. K., & Waters, P. M. (2001). Acute Compartment Syndrome in Children: Contemporary Diagnosis, Treatment, and Outcome. Journal of Pediatric Orthopaedics, 21(5), 680-688.

Investor Contact

Philip Trip Taylor

Gilmartin Group



415-937-5406



EN
05/09/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on OrthoPediatrics Corp

 PRESS RELEASE

OrthoPediatrics Corp. Announces Distribution Agreement with MY01 Inc.

OrthoPediatrics Corp. Announces Distribution Agreement with MY01 Inc. Advancing Care for Pediatric Trauma Patients WARSAW, Ind., Sept. 05, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics announced today a new distribution partnership with MY01, an innovative medical technology company focused on transforming the diagnosis of limb perfusion injuries. This collaboration will expand access to MY01’s Continuous Perfusion Sensing Technology™ (CPST™) Platform for children and adolescents, a population...

 PRESS RELEASE

OrthoPediatrics Corp. Announces the Appointment of Kelly Fischer to it...

OrthoPediatrics Corp. Announces the Appointment of Kelly Fischer to its Board of Directors WARSAW, Ind., Aug. 25, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the appointment of Kelly Fischer to its Board of Directors effective as of August 8, 2025. The appointment was made concurrent with the announcement of the retirement of Terry Schlotterback from the OrthoPediatrics Board of Directors, effective as of August 8, 2025. “We’re excited to ...

 PRESS RELEASE

OrthoPediatrics Corp. Reports Second Quarter 2025 Financial Results an...

OrthoPediatrics Corp. Reports Second Quarter 2025 Financial Results and Increases Full Year 2025 Revenue Guidance Second Quarter 2025 Revenue Surpasses $60 million for the First Time in Company History, and Increased Adjusted EBITDA by 58% year-over-year WARSAW, Ind., Aug. 05, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the second quarter ended June 30, 2025. Second Quarter 2025 and Business Highlights       He...

 PRESS RELEASE

OrthoPediatrics Corp. Announces Continued Expansion of Specialty Braci...

OrthoPediatrics Corp. Announces Continued Expansion of Specialty Bracing Division Into New Territories with Multiple Clinics WARSAW, Ind., Aug. 05, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its OrthoPediatrics Specialty Bracing (“OPSB”) division with multiple new clinics and entry into two new territories. The expansion of the OPSB division includes rapid expansion of greenfield clinic locations in California, Ohio, and ...

 PRESS RELEASE

OrthoPediatrics Corp. to Participate in the 45th Canaccord Genuity Ann...

OrthoPediatrics Corp. to Participate in the 45th Canaccord Genuity Annual Growth Conference WARSAW, Ind., Aug. 04, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer, and Fred Hite, Chief Operating Officer, and Chief Financial Officer, are scheduled to participate in a fireside chat at the 45th Canaccord Genuity Annual Growth Conference, held in Boston, MA. Event: 45th Canaccord Genu...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch